Jatcorp Reports Preliminary Final and Full Year Statutory Accounts
Key points
- Revenue from continuing operations decreased by 34% to $34.8m
- Gross profit from continuing operations decreased 41% to $11.4m
- Statutory net loss after tax for FY25 was $6.9 million, down 533% on the previous year
Full summary
Jatcorp Limited reported a 34% decrease in revenue from continuing operations to $34.8 million and a 41% decrease in gross profit from continuing operations to $11.4 million for the financial year ended 30 June 2025. The company's statutory net loss after tax for FY25 was $6.9 million, down 533% on the previous year. The increased loss was mainly driven by a dispute over the Neurio® brand in both Australia and China, which led to decreased sales of Neurio® products and impairment of Sunnya goodwill and excess stocks. The company accelerated its 'new channels' growth strategy, enhancing both online and offline market penetration, and launched seven new Moroka® products in FY25. Jatcorp remains confident in the strength and resilience of its long-term strategic plan, despite some short-term headwinds, and expects to achieve further uplift in Moroka® volumes through its strategic partnership with HS International. The company is also focused on expanding its footprint across Southeast Asia and growing its OEM manufacturing pipeline at the ANMA facility.
Outlook
Jatcorp remains confident in the strength and resilience of its long-term strategic plan, despite some short-term headwinds. The company expects to achieve further uplift in Moroka® volumes through its strategic partnership with HS International, driven by strong consumer demand for lactoferrin-based nutritional products and enhanced brand positioning in China's cross-border e-commerce market. Product innovation will also remain central to Jatcorp's growth strategy, with several new SKUs in advanced development. The company is also expecting to expand its footprint across Southeast Asia by forging new strategic distribution partnerships, and continue to grow its OEM manufacturing pipeline at the ANMA facility.
Summary generated by a large language model. Please interpret with care.